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Abstract
The purpose of this study was to determine if respiratory muscle strength training
(RMST) results in increased measures of respiratory function, improved vocal quality, and
improved quality of life as perceived by the participants. Data obtained by this study adds to
the body of knowledge regarding clinical use of RMST for SLPs working with patients with
Parkinson’s disease (PD). The study was comprised of a 13-week ABAB within-subject
design with a baseline period, five weeks of respiratory training (Phase 1), three weeks
without training (Detraining Phase), and five weeks with training (Phase 2). Three
individuals with moderate PD (1M, 2F) participated. They were taught to use the
PowerLung® respiratory training device and completed twice daily sessions of expiratory and
inspiratory muscle training, five days per week.
Outcome measures included maximum inspiratory and expiratory pressures (MIP and
MEP, respectively); forced vital capacity (FVC), percent predicted forced vital capacity
(FVC%), and forced expiratory volume in 1 second (FEV1); and sustained vowel phonation.
Measurements were taken at baseline, before and after detraining (where applicable), and at
the end of the study. Results indicated sustained or improved maximum respiratory pressures
for all participants from baseline to end of study. No participant showed significant changes
in FVC, FVC%, and FEV 1, and results of sustained vowel phonation varied.
Participants’ vocal quality was evaluated by three independent raters as well as the
subjects themselves and two conversation partners. Two CSD graduate students and one
certified SLP rated subjects’ voices at baseline and at the end of treatment using recorded
conversation samples and the GRBAS Voice Rating Scale (Hirano, 1981). Improvement in
vocal quality was perceived in two participants, and no change was seen in the other.
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Participants and two conversation partners completed the Perceptual Rating Form to report
on vocal quality. Participants noted improvement in vocal quality; conversation partners
reported both improvement and decline in various aspects of two participants’ vocal quality.
Participants completed two surveys regarding the impact of their voice on overall
communication and quality of life. These surveys, completed at the start of the study and at
completion of each phase, were the Voice Handicap Index (VHI) (Jacobson, et al., 1997) and
The Communicative Participation Item Bank General Short Form (Baylor et al. [under
review]). Responses from participants revealed inconsistent effects of RMST on quality of
life.
Results of this study demonstrate that the combination of inspiratory and expiratory
muscle strength training in individuals with moderate Parkinson’s disease may be a
beneficial treatment to improve respiratory function and positively impact vocal quality and
overall quality of life as it relates to communicative participation.
Results from this study revealed the potential for additional research on the effects of
RMST on pulmonary functions such as vital capacity (VC) and total lung capacity (TLC),
which are not dependent on maximum speed and effort. Additionally, further investigation
of RMST on quality of life is warranted in areas related to voice and communication, as well
as overall physical and emotional wellbeing.

v

Acknowledgements
Many people have offered their support, guidance, and assistance to help me
accomplish this thesis. I am extremely grateful and could not have done this without them.
First, I want to thank my family for their support and encouragement. To John and
Daniel, especially, thank you for your patience and endurance. Your support allowed me to
reach this goal.
My gratitude goes to Dr. Mathers-Schmidt for her help in setting up and carrying out
this, my first research study. Without her encouragement and guidance, I would have missed
a valuable learning experience. I would like to thank Dr. Zeine and Dr. Fraas for being a part
of my Review Committee and for the added assistance they each provided in the process of
completing this work.
To my research participants, I thank you for joining me in this endeavor. It was truly
a pleasure to work with and learn from each of you. You taught me much about Parkinson’s
disease and life, and I am better for having known you.
To Tim Kraft I offer my gratitude for his patience and willingness to assist me
technologically, even when it was not convenient for him. Yarrow Pospisil and Chelsea
Adams served as raters of vocal quality, and I am thankful for their flexibility and
collaborative efforts. I want to thank Chelsea further for her assistance entering data, along
with Maureen Hagan. Their attention to detail allowed me to progress with confidence.
Finally, thank you to my peers and fellow graduate students, whose encouragement
and support sustained me often and helped me to push forward.

vi

Table of Contents

Abstract………………………………………………………………………………………. iv
Acknowledgements…………………………………………………………………………....vi
List of Figures and Tables……………………………………………………………..……..viii
Introduction…………………………………………………………………………………… 1
Method.……………………………………………………………………………………….. 7
Results……………………………………………………………………………………….. 12
Discussion…………………………………………………………………………………… 17
Conclusion……………………………………………………………………………………27
References…………………………………………………………………………………… 29
Appendices…………………………………………………………………………………... 33

vii

List of Figures
Figure 1……………………………………………………………………………………… 13
Figure 2……………………………………………………………………………………… 13
Figure 3……………………………………………………………………………………… 15
List of Tables
Table 1…………………………………………………………………………………………7
Table 2………………………………………………………………………………………..14
Table 3………………………………………………………………………………………. 14
Table 4………………………………………………………………………………………. 14
Table 5………………………………………………………………………………………. 16
Table 6………………………………………………………………………………………. 16
Table 7………………………………………………………………………………………. 17
Table 8………………………………………………………………………………………. 17
Table A1…………………………………………………………………………………….. 34
Table A2…………………………………………………………………………………….. 34
Table A3…………………………………………………………………………………….. 35
Table B1…………………………………………………………………………………….. 37
Table B2…………………………………………………………………………………….. 37
Table B3……………………………………………………………………………………... 38
Table C1……………………………………………………………………………………... 40
Table C2……………………………………………………………………………………... 40
Table C3……………………………………………………………………………………... 40

viii

List of Appendices
Appendix A………………………………………………………………………………….. 33
Appendix B………………………………………………………………………………….. 36
Appendix C……………………………………………………………………………….…. 39

ix

Parkinson’s disease (PD) is a progressive neurologic disorder resulting from reduced
dopamine production in the basal ganglia and brainstem. The disease is characterized by
resting tremor, muscular rigidity, akinesia and/or bradykinesia, and postural instability
(Yorkston, Beukelman, Strand, & Hakel, 2010). Among the sequelae of PD are difficulties
with breathing, communicating, swallowing, and coughing, as well as cognitive decline, all
of which typically worsen as the disease progresses (Miller, Noble, Jones, & Burn, 2006;
Sapienze, Troche, Pitts, & Davenport, 2011). Cognitive deficits may include misperceptions
of speech production, emotional responses, and/or time and space, which can present
respectively as reduced vocal loudness, overt demonstration of emotion, and changes in gait
and/or other motor movements (Hirsch & Farley, 2009; Kwan & Whitehill, 2011).
Although the cause of respiratory dysfunction associated with PD has not been
confirmed, Silverman et al. (2006) reported evidence pointing toward lower and upper
airway obstruction, lower airway restriction, respiratory muscle weakness, and/or respiratory
muscle dysfunction. The authors identified numerous consequences of pulmonary
dysfunction: reduced maximal inspiratory and expiratory airflow/pressures, abnormal flow
volume loops, reduced peak expiratory airflow rates, decreased vital capacities, and impaired
activity of respiratory muscles, particularly the intercostal muscles. They further suggested
that persons with PD experience chest wall rigidity, which cannot be overcome due to
weakened respiratory muscles. This has been thought to contribute to reduced lung volumes
and respiratory pressures that negatively impact swallow, cough, and speech functions.
Speech and voice changes affect approximately 75-90% of persons with PD,
interfering with their ability to communicate effectively (Miller at al., 2006; Sapir et al.,
2002). Hypokinetic dysarthria is a common consequence of PD, with perceptual features
1

associated with the characteristic reduced range of motion and bradykinesia, which includes
slowness of movement and difficulty initiating movement (Brookshire, 2007; Duffy, 2005).
According to Duffy (2005) and Yorkston et al. (2010), reduced range of motion contributes
to monopitch, monoloudness, short phrases, short rushes of speech, and imprecise
consonants. Difficulties in initiating movement may lead to inappropriate silences. Voice
abnormalities such as breathiness, voice harshness, and low pitch are consequences of
laryngeal musculature rigidity.
Such changes in speech and voice have been shown to negatively impact quality of
life in individuals with PD by creating barriers to communicative participation. During
interviews conducted by Miller et al. (2006), adults with PD expressed greatest concerns
regarding “detrimental effects of the effort required to overcome physical and mental
limitations for anything beyond short periods….Communication changes directly impacted
socialization, from apprehension at interaction to social withdrawal” (pp. 236-237). These
comments reveal the importance of treatment options that promote physical and mental
stamina in persons with PD to counteract potential decline in quality of life as the disease
progresses.
Qualitative research by Baylor, Burns, Edie, Britton, and Yorkston (2011) further
highlights the complexity of managing a disease and its impact on communication and
quality of life. Subjects from different patient populations, including those with PD,
identified factors that influenced communicative participation, including familiarity with
communication partners, effects of the communication disorder and other health symptoms,
and environmental influences (e.g. background noise, situations that demanded speed, etc.).
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Such reports should prompt SLPs to consider communication treatment as one component of
overall disease management for their patients.
Respiratory muscle strength training (RMST) has been proposed as a way to
overcome the negative effects of muscle weakness and motor dysfunction that impact
communication in persons with PD (Saleem, Sapienza & Okun, 2005; Silverman, et al.,
2006; Troche et al., 2010). Adequate respiratory muscle strength is critical to establishing
the necessary balance between ventilatory requirements and ventilatory capacity, a balance
which is often compromised for persons with neurodegenerative diseases (Sapienza &
Wheeler, 2006). Reduced strength and coordination of respiratory muscles, including
intercostals, abdominal muscles, and the diaphragm, contribute to low lung volumes and
insufficient positive subglottal pressure. The latter is necessary for adequate loudness levels
of speech, extended durations of speech, and stress contrasts (Putnam & Hixon, 1987, as
cited in Sapienza & Wheeler, 2006). The focus of RMST is to increase the force-generating
capacity of respiratory muscles (Sapienze et al., 2011) based on principles of resistance
training commonly used to strengthen limb muscles. Respiratory muscles, including the
diaphragm, are skeletal muscles and share structural and functional characteristics with limb
muscles; therefore, they should respond to training in the same way limb muscles respond
when an appropriate physiological load is applied (Enright, Unnithan, Heward, Withnall, &
Davies, 2006). Strengthening of limb muscles results in both neural adaptations (i.e. increase
motor unit excitability, enhanced coordination, and more efficient motor programming) and
muscular adaptations (e.g. increased muscle diameter). The same has been shown to occur in
strengthened respiratory muscles (Saleem, Sapienza, & Okun, 2005).
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Inspiratory and expiratory muscle strength training (IMST and EMST, respectively)
have been studied both separately and together in various populations, including healthy
adults (Enright et al., 2006), athletes (Guenette et al., 2006), and persons with chronic
obstructive pulmonary disease (Battaglia, Fulgenzi, & Ferrero, 2009), paradoxical vocal fold
movement (Mathers-Schmidt & Brilla, 2005), multiple sclerosis (Chiara, Martin, &
Sapienza, 2007), and PD (Silverman et al., 2006). Reduced rigidity of the thorax is a
particularly beneficial IMST outcome in persons with PD, as strengthened muscles more
fully expand the rib cage, thereby increasing lung volumes (Silverman et al, 2006). EMST
has been shown to increase positive airflow essential for speech, cough production, and
swallowing (Kim & Sapienza, 2005; Sapienze et al., 2011; Troche et al., 2010). It has been
suggested that a combination of EMST and IMST may be an effective method of addressing
deficits in these various functions, as well as in lung volume and airflow (Battaglia et al.,
2009, Silverman et al., 2006).
RMST relies on concentrated and repetitive efforts to maintain existing respiratory
muscle function, retrain respiratory muscles whose function has declined, and improve neural
connections in the brain (Hirsch & Farley, 2009; Kleim & Jones, 2008; Saleem et al., 2005).
For persons with PD, this can mean reduced dyskinesia or bradykinesia of respiratory
muscles, which promotes greater control over both inspiration and expiration. Additionally,
the principle of transference (Kleim & Jones, 2008) suggests that strengthening of respiratory
muscles may increase strength of peripheral muscles and neural connections to them,
including muscles of the larynx. This was evidenced by reports from Sapienza (2008) that
strength of the diaphragm is positively correlated to strength of the posterior cricoarytenoid
muscle (PCA), as control of both muscles occurs in the brainstem. The author suggests a
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positive correlation between increased activation of the diaphragm and the PCA with IMST.
It could be presumed, then, that increased activation of the PCA would increase the glottal
aperture and improve vocal fold vibration. In conjunction with increased excursion of the
thoracic cage on both inhalation and exhalation, then, resistance to airflow would reduce,
thereby enhancing respiratory support for achieving optimal vocal loudness and quality.
Indeed, improvement in vocal quality has been linked to increasing respiratory drive and
vocal fold movement in persons with PD (Sapir et al., 2002).
Measurements of maximum inspiratory and expiratory pressures at the mouth (MIP
and MEP, respectively) have long been accepted as valid tests of a person’s general
inspiratory and expiratory abilities (Polkey, Green, & Moxham, 1995). In recent research,
pressure threshold training has been the means of strengthening respiratory muscles and
increasing maximum pressures (Baker et al., 2005; Kim & Sapienza, 2005; Saleem et al.,
2005; Sapienza et al., 2011; Troche et al., 2010). Unlike resistance training, pressure
threshold training does not allow the trainee to adjust the airflow rate during the training
stimulus. In other words, a steady airflow must be maintained, and training is not susceptible
to variations in users’ airflow rates (Saleem et al., 2005). According to Enright et al. (2006),
failure to maintain an overload on the muscles throughout training accounts for conflicting
findings regarding benefits of IMST in previous research. In pressure threshold training, the
subject receives short durations of consistent, high intensity exercise targeted specifically at
respiratory muscles.
Baker et al. (2005) reported evidence from limb strength training studies that within
four weeks of exercise, neural adaptations occur, accounting for significant improvement in
strength. Beyond four weeks, strength continues to improve, possibly as a result of
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peripheral or structural changes. Furthermore, research has shown that strengthened limb
muscles maintain strength for two to four weeks after the end of a training program (Coyle et
al., 1984; Hortobagyi et al., 1993; Mujika & Padilla, 2001, as cited in Baker et al., 2005).
Baker and colleagues (2005) reported that studies of RMST which included detraining
periods showed minimal loss of strength up to two months without training (Baker et al.,
2005; Romer & McConnell, 2003) and post-training strength above baseline measurements
after six months (Gosselink et al, 2000, as cited in Baker, et al., 2005).
The purpose of this study was to determine if specific inspiratory and expiratory
muscle training results in increased measures of respiratory function, primarily MIP and
MEP, improved vocal quality, and improved quality of life as perceived by the participants.
Data obtained by this study will add to the body of knowledge regarding clinical use of
RMST for speech-language pathologists (SLPs) working with patients with PD. It is
proposed that exercise programs specifically designed to strengthen respiratory muscles may
alter the symptoms of the disease by improving respiratory function, voice quality, and
overall quality of life.
The following hypotheses were made in the present study:
1. With RMST, participants’ MIP/MEP measurements will increase.
2. Increased MIP/MEP will result in increased lung volumes and capacity, as
measured by FVC, FVC%, and FEV1, and sustained vowel phonation.
3. Improved respiratory function will lead to improved vocal quality, greater
participation in social and communicative interactions, and overall improved
quality of life.
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Method
Participants
Six individuals with idiopathic Parkinson’s disease (2 females, 4 males) initially
participated in the study. Three male participants withdrew from the study before its
completion, due to scheduling and health complications. Ultimately, three participants
completed the study. Table 1 presents the demographic data for these participants.
Table 1. Demographics of Participants
Subject
P1

Gender
M

Age

Height
(inches)

Weight
(lbs.)

64

70

225

P2

F

68

63.5

140

P3

F

44

65.5

135

56
(+12)

66.75
(+3.25)

180
(+45)

Mean
(SD)
Range:

Education
Bachelor’s
Degree
Master’s degree
High School
Diploma

Years
since
diagnosis
3

Smoker
within 5
years
No

MoCA
Score

8.5

No
Yes (~5
cig/day)

29/30
23/30

3
5.75
(+2.75)

24/30

26
(+ 3)

Medical clearance for each participant was obtained from his or her primary doctor
and/or neurologist prior to the start of research. Structural/functional examination of each
participant’s oral and facial structures revealed no physical impairments that might interfere
with completion of exercises or measurement tasks. Additionally, each participant
demonstrated adequate respiratory driving pressure for speech by sustaining a steady
respiratory driving pressure of 5cm H2O for 5 seconds (Netsell & Hixon, 1978).
The Montreal Cognitive Assessment (MoCA) (Nasreddine, 2010) was administered
prior to baseline measurements. This rapid screening instrument assesses cognitive domains
of attention and concentration, executive functions, memory, language, visuoconstructional
skills, conceptual thinking, calculations, and orientation. A score of 26 or above is
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considered normal. Participant 2 scored within normal limits, while Participants 1 and 3
scored below normal limits.
Participants were not involved in any other therapy addressing respiratory, speech, or
voice function. Participants reported being “on” in their medication cycles at all training and
measurement sessions with the examiner, and they were instructed to refrain from altering
other exercise programs for the duration of the study.
The research compliance officer of Western Washington University conducted the
human subjects review and approved the study. All participants provided informed consent
prior to commencing the study.
Materials and Procedure
The study was comprised of a 13-week ABAB within-subject design with a baseline
period, five weeks of respiratory training (Phase 1), three weeks without training (Detraining
Phase), and five weeks with training (Phase 2). Training phases consisted of twice daily
sessions of expiratory and inspiratory muscle training, using a PowerLung® trainer
(PowerLung, Inc., Houston, TX), five times per week. Instruction of respiratory muscle
strength training, weekly meetings between participants and the examiner, and outcome
measurements were performed in a research laboratory, with a noise level of no greater than
20 dB and adequate lighting.
Baker et al. (2005) cited a number of studies in which four-week respiratory muscle
strength training regimens were followed with both healthy and patient populations. The
four-week duration was based on evidence from limb strength training studies. According to
the authors, neural adaptations within the first four weeks appear to be the primary source of
increased muscle strength; beyond four weeks, peripheral or structural changes may account
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for improvements in strength. The current study followed a 5-week protocol to allow for
maximum benefit for subjects with compromised respiratory systems and greater potential
for strengthening of peripheral laryngeal musculature.
Inclusion of a detraining phase allowed the researcher to examine participant
behavior upon removal of treatment. In ABAB design, a return to baseline performance
following detraining typically indicates distinct treatment effect (Schiavetti, Metz, &
Orlikoff, 2011). However, evidence shows that the effects of skeletal muscle strengthening
can last up to four weeks after training has ceased (Coyl et al., 1984; Hortobagyi et al., 1993;
Mujika & Padilla, 2001, as cited in Baker et al., 2005). Therefore, in the current study, it was
anticipated that participants’ maximum respiratory pressures would either be maintained or
decline toward baseline measurements with removal of treatment.
RMST exercise.
PowerLung® is a hand-held, spring-loaded device designed to strengthen respiratory
muscles and equipped with independently adjustable control dials to set levels of resistance
for both inhalation and exhalation. The device is set to a challenging level of resistance,
which ideally, according to Enright et al. (2006), is 60-80% of the individual’s maximum
inspiratory and expiratory pressure abilities. Users must generate enough pressure when
inhaling or exhaling to open and maintain opening of a one-way valve, allowing air to pass
through the valve. The resistance creates a load against which respiratory muscles must
work and overcome, increasing muscle strength and endurance with continued exercise
(PowerLung, Inc., 2013).
Using the PowerLung®, participants were coached to produce two sets of 10
repetitions for each task (i.e. inhalation and exhalation) per exercise session. One session was
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to be completed in the morning and another in the afternoon or evening each day, five days a
week, for five weeks. The participants met individually with the examiner once each week.
During these meetings, participants demonstrated use of the PowerLung®, and the examiner
modified the resistance levels according to performance gains, based on manufacturer
guidelines.
Participants were seated and wore nose clips when performing RMST exercises. The
examiner instructed each participant on the use of the PowerLung® and monitored
diaphragmatic breathing and adequate lip seal during the exercises. Once a participant
demonstrated correct independent use of the device, he/she completed training sessions four
days per week at home and one day per week in the university clinic under the supervision of
the examiner. Participants kept a daily exercise log for the duration of the study, in which
they recorded all RMST exercises as well as other exercises completed at any time during the
study and any changes made to resistance levels. The examiner reviewed exercise logs at
weekly visits at the university clinic.
Outcome measures.
Respiratory function measurements.
Changes in respiratory function were determined by measuring maximum inspiratory
pressure (MIP) and maximum expiratory pressure (MEP) before and after Phase 1, after the
Detraining Phase, and upon completion of Phase 2. The MIP and MEP measures quantify the
respiratory muscle strength in terms of force generation. The measurement apparatus was
consistent with that used by Mathers-Schmidt and Brilla (2005). It was comprised of a
mouthpiece with a two-way valve connected via a vacuum hose to the electronics of a
calibrated custom pressure sensing device, with output displayed on a Fluke True-rms
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Multimeter (Model 110). Participants stood and wore nose clips during all MIP and MEP
measurements.
Participants’ forced vital capacity (FVC), percent predicted forced vital capacity
(FVC%), and forced expiratory volume in 1 second (FEV1) were measured using a
SpiroVision 3+ Version 8.1a Diagnostic Spirometer for Windows (Futuremed, Granada Hills,
CA). Participants stood and wore nose clips during the tasks. Measurements were obtained
at baseline and after Phases 1 and 2.
Finally, sustained vowel phonation (“ah”) was measured at baseline and at the end of
Phases 1 and 2. Participants were seated, and the same timer displaying seconds was used
for all measurements.
Vocal quality measurements.
The GRBAS Voice Rating Scale (Hirano, 1981) was used to rate participants’ quality
of voice based on grade, roughness, breathiness, asthenics (i.e. power), and strain. Voice
samples were obtained prior to Phase 1 and after completion of Phase 2. Three judges,
including two second-year CSD graduate students and a certified SLP, independently rated
recorded voice samples. Inter-rater reliability was found to be high at both baseline
(intraclass correlation coefficient [ICC] = 0.99) and end of study (ICC = 0.93).
Participants indicated self-perception of their voices and tendencies of vocal use
using the Perceptual Rating Form (LSVT Global, Inc., 2012). This survey was completed at
baseline, after Phase 1, and after Phase 2. Items include such characteristics as vocal quality
(e.g. hoarseness, loudness, etc.) intelligibility, and use of speech (e.g. participation/initiation
of conversation). Because PD commonly impacts an afflicted person’s self-perception
abilities (Hirsch & Farley, 2009; Kwan & Whitehill, 2011), each participant was asked to
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recruit a conversation partner familiar with the participant’s typical speech to complete the
survey, as well. Comparison of results from participants to those of their conversation
partners was used to gain insight into such potential differences in perceptions. Two
conversation partners were available to do so and submitted forms at the end of each phase
for comparison to participants’ self-perception ratings.
Impact on quality of life measurements.
Participants completed two surveys regarding the impact of their voice disorder on
communicative participation and quality of life. These surveys were completed at the start of
the study and again after each phase. Voice Handicap Index (VHI) (Jacobson, et al., 1997)
measures individuals’ perception of their voices and how their voices affect them physically,
functionally, and emotionally. The Communicative Participation Item Bank General Short
Form (Baylor, Yorkston, Eadie, Kim, Chung, & Amtmann [under review]) examines the
extent to which voice and/or speech impairments impact individuals’ communicative
participation.
Results
Respiratory measurements
MIP and MEP.
All participants demonstrated maintenance or improvement of both MIP and MEP
from beginning to end of the study (Figures 1 and 2). Two instances of decline were noted in
MIP measurements and three instances in MEP; however, recovery was noted in all but one
case. The latter occurred at the final measurement of the study, leaving no opportunity to
determine subsequent effects. In both areas of measurement, Participant 1 demonstrated
maintenance of ability with minor fluctuations. Participant 2 showed marked improvement
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in MIP; however, measurements of MEP indicate initial decline followed by recovery to
slightly above baseline ability. Participant 3 demonstrated consistent improvement in both
MIP and MEP throughout most of the study. Although the participant’s final measurement
of MEP resulted in a decline, notable improvement was seen from beginning to end of study.

cm H20

Figure 1. Maximum Inspiratory Pressure (MIP)
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Figure 2. Maximum Expiratory Pressures (MEP)
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FVC, FVC%, and FEV1.
Participants’ forced vital capacity (FVC), percent predicted forced vital capacity
(FVC%), and forced expiratory volume in 1 second (FEV1) are displayed in Tables 2, 3, and
4, respectively. Slight decline was noted in all participants from baseline to end of study;
however, Participants 1 and 2 demonstrated above normal FVC, FVC%, and FEV1 levels
across all measurements. Participant 3 demonstrated below normal measurements at baseline
and did not improve with RMST exercises.
Table 2.
Participant
1
2
3

Baseline
6.56L
3.46L
2.85L

Ph 1, Wk 5
6.73L
3.22L
2.89L

Detraining

Forced Vital Capacity (FVC)
Ph 2, Wk 1
5.14L
3.06L
2.72L

Ph 2, Wk 5
5.09L
3.06L
2.72L

Note: Ph = Phase; Wk = Week; L= Liters

Table 3.
Participant
1
2
3

Baseline
141.4%
115.2%
74.0%

Ph 1, Wk 5
145.0%
107.1%
75.4%

Detraining

Percent Predicted Forced Vital Capacity (FVC%)
Ph 2, Wk 1
110.7%
101.7%
71.1%

Ph 2, Wk 5
109.7%
103.2%
71.1%

Note: Ph = Phase; Wk = Week

Participant

Baseline

Ph 1, Wk 5

1
2
3

6.47L
3.06L
2.77L

6.6L
3.02L
2.87L

Detraining

Table 4.
Forced Expiratory Volume in 1 Second (FEV1)
Ph 2, Wk 1
4.21L
2.39L
2.36L

Ph 2, Wk 5
4.11L
2.53L
2.38L

Note: Ph = Phase; Wk = Week; L= Liters

Sustained vowel phonation.
Figure 3 displays measurements of sustained vowel phonation (“ah”). Each
participant demonstrated overall improvement from baseline to end of study. Despite this
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improvement, Participant 1 remained below normal limits. Participants 2 and 3 began the
study with maximum phonation times below normal limits; however, both were within
normal limits by the end of Phase 1. Participant 2 demonstrated improvement during Phase 1
but declined in Phase 2, yet improving overall and staying within normal limits. Participant 3
exhibited steady improvement throughout the study and demonstrated the greatest increase of
phonation time.

Seconds

Figure 3. Duration of Sustained
Vowel Phonation
25
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P1
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P2

5

P3

0
Baseline

End Phase 1

End Phase 2

Note: P = Participant

Subjective Measurements of Voice and Communication Participation
GRBAS Scale.
Three judges (two second-year CSD graduate students and a certified SLP) rated
participants’ quality of voice using GRBAS Voice Rating Scale (Hirano, 1981) pre- and postintervention. Scores reflected the amount of abnormality in vocal quality. Lower numbers
represent less abnormality than higher numbers; therefore, low scores are preferred. Results
revealed improved vocal quality in Participants 1 and 2, and no change in vocal quality in
Participant 3 (Table 5).
Table 5.
Summary of GRBAS Ratings
P1
Rater
1
2

Baseline
7
7

P2
End Ph 2
6
4

Baseline
3
2

P3
End Ph 2
1
2

Baseline
2
2

End Ph 2
2
2

15

3
Average
Rating

8

7

3

2

2

2

7.3

5.7

2.7

1.67

2

2

Perceptual Rating Form.
A summary of responses to the Perceptual Rating Form (LSVT Global, Inc., 2012) is
presented in Table 6 and indicates areas of improvement and decline, as perceived by
participants and their conversation partners. Detailed responses appear in Appendix A.
Participants noted more areas of improvement than decline from beginning to end of study.
Two participants recruited conversation partners, who rated fewer areas of improvement than
did the participants.
Table 6.
Summary of Responses to Perceptual Rating Form
Participant Responses

Conversation Partner Responses

Participant

Number of Areas
of Improvement

Number of Areas
of Decline

Number of Areas
of Improvement

Number of Areas
of Decline

1
2
3

7
8
9

3
2
1

4
2

6
8

Note: No conversation partner rated typical voice for P1.

Impact on Quality of Life Measures
Voice Handicap Index (VHI).
The Voice Handicap Index (Jacobson et al., 1997) was used to measure participants’
perception of their voices and how their voices affected them physically (P Scale),
functionally (F Scale), and emotionally (E Scale). Participants completed the VHI
independently at baseline, after the Detraining Phase, and after Phase 2. Results generate a
number score per category, which corresponds to a severity level of impact from mild to
severe. Table 7 presents overall severity ratings from baseline to end of study. Detailed
results including raw scores for each scale are included in Appendix B. While minor
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fluctuation occurred in distinct categories, overall severity ratings improved for Participant 1
and remained consistent for Participant 2. Severity increased slightly for Participant 3.
Table 7.
Levels of Severity per Voice Handicap Index (VHI)
Participant
1
2
3

Baseline
Moderate-Severe
Mild
Moderate-Severe

End Phase 2
Mild-Moderate
Mild
Severe

Communication Participation Item Bank – General Short Form.
The Communication Participation Item Bank General Short Form (Baylor et al.,
under review) was used to measure the extent to which participants’ communicative
participation was impacted by voice and/or speech impairments resulting from Parkinson’s
disease. Table 8 indicates ratings of interference from mild to severe at baseline and end of
study. Summary scores, IRT theta scores, and T scores at baseline, beginning of Phase 2,
and at end of study are presented in Appendix C. Higher scores indicate less interference in
participation than lower scores and, therefore, are preferable. Results varied with one
participant demonstrating reduced interference in participation, one participant showing no
change in interference level, and one participant exhibiting slight increase in interference.
Table 8.
Levels of Severity per Communication Participation Item Bank – General Short
Participant
1
2
3

Baseline
Mild
Mild-Moderate
Moderate

End Phase 2
Mild
Moderate
Mild-Moderate
Discussion

This study investigated the impact of combined inspiratory and expiratory muscle
strength training on respiratory functions, vocal quality, and quality of life in three
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individuals with moderate PD. In response to RMST exercises, all participants sustained or
improved respiratory muscle strength, as measured by maximum inspiratory and expiratory
pressures. Likewise, participants maintained or improved strength during a three-week
detraining period. However, decline in FVC, FVC%, and FEV1 measurements was seen
across the participants, indicating no benefit from RMST exercises with regard to lung
capacity. Measurements of sustained vowel phonation time, vocal quality, and quality of life
revealed varied results, reflecting the complexity of the disease and the influence of external
factors on RMST effects.
MIP and MEP

Although findings in MIP and MEP measurements varied across participants,
beginning- to end-of-study results indicate either increase or maintenance of respiratory
muscle strength for each individual following treatment with RMST exercises. Increases in
MIP measurements were seen in Participants 2 and 3, while inspiratory muscle strength, as
measured by MIP, was maintained by Participant 1. Marked increase in MEP measurements
was demonstrated by Participant 3, and minimal MEP improvement was noted in Participant
1. Participant 2 demonstrated initial MEP decline followed by improvement slightly above
baseline by the end of the study.
Strength training of respiratory muscles is hypothesized to be similar to that of limb
muscles, in which strength is typically seen within four weeks of training, potentially
resulting from neural adaptations (Baker, 2005; Saleem et al., 2005; Silverman et al., 2006).
However, Baker et al. (2005) reported that individuals with PD may experience slower neural
adaptation than healthy individuals. Postponement in increase of strength in the participants
of this study may reflect such delays in neural adaptations. This suggests that clinicians
using RMST as treatment for clients with PD might anticipate more dramatic results after
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four weeks of exercises. However, as demonstrated by this study, results may vary with
individuals. Although closer examination of each participant gives insight into potential
reasons for this variance, these findings suggest the need for additional research, including
short-term efficacy studies as well as longitudinal studies with larger sample sizes.
Participant 1 exhibited temporary decline in measurements of both MIP and MEP at
Week 3 of Phase 2. Review of homework records revealed no change in exercise routines or
device settings, and subsequent measurements taken in Week 5 resulted in improved strength
to levels near or above previous pressure levels. Likewise, Participant 3 demonstrated sudden
decline in MEP levels during the final measurement. Because no subsequent measures were
taken, it is unknown whether she would have regained previous pressure levels. Review of
other studies reveals similar occurrences, indicating that fluctuations in strength appear not to
be abnormal in RMST programs (Baker et al., 2005; Mathers-Schmidt & Brilla, 2005; and
Saleem et al., 2005).
A variety of external factors, such as medication, personal events, and/or overall
physical condition, may have impacted participants’ performance during data collection.
Individuals in this study frequently reported having “good days” and “bad days”. In addition
to daily medication, for example, Participant 1 received periodic intravenous nutrient
therapy. On a day when MIP/MEP measurements were taken, the participant received IV
nutrient therapy prior to meeting with the researcher. This may have negatively impacted his
performance while MIP and MEP measurements were taken. On the other hand, Participant
3 demonstrated unusually high expiratory pressure levels in Week 3 of Phase 2. During this
testing period, the participant commented on feeling more rested and having higher energy
levels, which she attributed to RMST exercises, although that cannot be directly determined.
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The potential influence of such external factors complicates determination of the efficacy of
RMST.
Other changes in maximum pressures may be due to progression of the disease.
Cognitive abilities, for example, are known to decline over time in individuals with PD.
Participant 2 had the greatest number of years since diagnosis; therefore, one might anticipate
greater decline from this participant than from the others. In fact, Participant 2 expressed
difficulty coordinating the steps involved in performing the MEP measurement task during
Phase 2, and results of MEP measurements did indeed reflect decline in performance. At
baseline, Participant 2 was determined to be within normal cognitive limits, based on the
MoCA screening tool. However, progression of the disease over the span of the study may
have impacted her ability to perform the MEP task. Interestingly, however, she did not
demonstrate similar difficulty when performing the MIP task, which differed only in the
direction of airflow and subsequent physical sensation. MIP measurements demonstrated
increase at the same time that MEP measurements showed decrease. Furthermore, expiratory
exercises with PowerLung® were successfully achieved by the participant with no complaints
of the challenges experienced during measurement tasks. This resulted in regular increases
to the resistance level on the device. Consequently, the participant’s performance on
measurement tasks inaccurately reflected abilities demonstrated with the exercise device.
Following the detraining phase, Participants 1 and 3 sustained or showed slight
improvement in maximum inspiratory and expiratory pressures. This is consistent with
findings in other studies in which the strength-training effect remained after exercising
ceased (Baker et al., 2005; Mathers-Schmidt & Brilla, 2005; Saleem et al., 2005). Results for
Participant 3, however, showed sharper improvement when treatment was removed.
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All participants reported having ceased RMST exercises during this three-week
phase. While increases in measurements were unexpected, it may be that, because
participants’ respiratory muscle strength had improved, their ability to engage in physical
activity increased. Such increase in physical activity may have exercised respiratory muscles
naturally, thereby continuing to strengthen them in spite of the removal of treatment.
Participant 3 demonstrated the greatest increase, particularly in MEP measurements.
Although participants were instructed not to alter other exercise programs for the duration of
the study, Participant 3 changed residences while the study was conducted, which inevitably
added physical activity to her daily life. Furthermore, this participant reported feeling more
energetic since having begun respiratory exercises, as well as sleeping better and
experiencing less pain, particularly in her shoulders as a result of improved breathing posture
required by the treatment. Considering these reports as well as the activities of Participant
3’s life during the detraining phase, it is conceivable that respiratory muscle strength
improved in the absence of direct treatment, leading to higher MIP and MEP measurements
post-detraining. Such an effect should be considered a positive potential consequence of
RMST treatment; however, as demonstrated by this study’s participants, results will vary
across individuals.
The effects of detraining are clinically significant when creating long-term treatment
goals and determining the need for maintenance programs. Information regarding decline in
strength and/or function following termination of treatment may influence client motivation
to continue RMST exercises. Data from more time post-treatment is needed to better
understand detraining effects on RMST treatment.
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FVC, FVC%, and FEV1
Throughout the study, above normal limits were achieved by two of the three
participants in FVC, FVC%, and FEV1 measurements. Minimal decline was noted in
Participant 3, who remained below normal limits. This participant reported being a cigarette
smoker at the time of the study, which may account for the reduced respiratory function, as
compared to Participants 1 and2. The results are consistent with other studies in which FVC,
FVC%, and FEV1were used as outcome measurements of inspiratory and/or expiratory
muscle strength training (Baker et al., 2005; Enright et al., 2006; Sapienze et al, 2011; and
Shahin et al., 2008). In these studies, little significant change was noted in these
measurements. Enright et al. (2006) reported no change in FVC, FVC%, and FEV1, yet they
did note improvements in vital capacity (VC) and total lung capacity (TLC) in the treatment
group with no such change in the control group. Interestingly, FVC, FVC%, and FEV1 are
speed- and effort-dependent tasks, while VC and TLC are not. Presumably, individuals with
PD may experience greater difficulty completing tasks requiring effort and speed, as opposed
to those that do not. Evidence from Enright and colleagues suggests that FVC, FVC%, and
FEV1 alone may not present a complete picture of the effects of RMST on respiratory
capacity. Because the current study did not measure VC and TLC, the outcome of RMST on
participants’ respiratory functions may not be fully represented. Additional research in this
area is suggested to further explore the effects of RMST on pulmonary abilities.
Sustained vowel phonation
Results of sustained vowel phonation indicate that maximum respiratory pressures
directly impact breath support necessary for speech. Participants 1 and 3 demonstrated
increased maximum phonation time (MPT) consistent with increases in MIP/MEP
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measurements throughout the study. Although Participant 2’s MPT decreased during Phase
2, despite simultaneous increases in MIP and MEP, overall results showed improvement
from beginning to end of the study. A contradiction such as this suggests that adequate
MIP/MEP, while influential, may not be the only requirement for sustaining phonation.
Nevertheless, overall improvement in all participants is consistent with evidence from
Sapienza and Wheeler (2006) and Putnam and Hixon (1987, as cited in Sapienza & Wheeler,
2006) that increasing strength of expiratory muscles, especially, assists in generating positive
pressures necessary for increased sound durations. According to these authors, such muscle
strength is particularly beneficial for individuals for whom inspiratory volumes are limited
and subglottal pressure is compromised. For persons with PD, these limitations often present
as short phrases and/or short rushes of speech (Duffy, 2005; Yorkston et al., 2010). RMST,
therefore, appears to be a viable treatment option for addressing these effects of PD. Indeed,
in this study, two participants achieved sustained vowel durations within normal limits as a
result of RMST.
Vocal quality
In addition to their findings regarding duration of speech, Sapienza and Wheeler
(2006) reported that airway pressure contributes to quality of voice. In the current study,
vocal quality appeared to be positively impacted by RMST exercises. Participants who were
judged to have the greatest vocal abnormality demonstrated the greatest improvement
following RMST exercises. Participant 2 was judged to have the best vocal quality at
baseline and maintained that vocal quality through the study.
Interestingly, Participant 1, who showed greatest improvement in vocal quality,
demonstrated the least amount of change in maximum inspiratory and expiratory pressures.
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One might expect consistency in results between the two measures. As with sustained vowel
phonation, this disparity suggests that factors in addition to maximum respiratory pressures
may influence vocal quality. Transference, a principle of experience-dependent neural
plasticity, as well as the 13-week duration of the study may have led to enhanced
performance of peripheral laryngeal muscles and, hence, improved vocal quality (Baker et
al., 2005; Kleim & Jones, 2008; Sapienza, 2008). Sapir and colleagues (2002) purported that
enhancement of the PCA muscle secondary to diaphragm strengthening may improve vocal
fold vibration. Based on results from studies of limb muscles, Baker et al. (2005) maintained
that peripheral and structural changes potentially contribute to strengthening of muscles
when exercise programs extend beyond four weeks. These potential secondary effects, in
addition to increases in maximum respiratory pressures, may explain perceived
improvements in participants’ vocal quality.
Improved vocal quality was further reflected by responses to the Perceptual Rating
Form. Although each participant noted decline in some categories, these tended to be in
areas of articulation. Loudness and vocal quality, characteristics anticipated to be more
directly impacted by increases in respiratory pressures, were generally reported as having
improved. Two participants elicited ratings from conversation partners, in addition to
completing the questionnaire themselves. In both cases, conversation partners noted fewer
overall gains than the participants reported. However, improvements that were identified
reflected changes in vocal quality. All participants indicated greater involvement in
conversation after having completed RMST exercises, while conversation partners perceived
more variable changes in this area.
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Because of the subjective nature of questionnaires, one logically would anticipate
some differences between perceptions of participants and their conversation partners.
However, decline in self-perception accuracy is commonly associated with PD (Kwan and
Whitehill, 2011) and also may have contributed to discrepancies participants’ and
conversation partners’ responses. Nevertheless, RMST appears to have contributed to
improvements in vocal quality as perceived by external raters and the participants
themselves.
Quality of life
Engagement in physical strengthening activities is known to increase endorphins and
improve overall sense of wellbeing in individuals who exercise. Exercise in general is
recommended to persons with PD for maintenance of muscle strength and flexibility
(Goodwin, Richards, Taylor, Taylor, & Campbell, 2008). It also is thought to be beneficial
for combating depression and improving overall mental health (Bridgewater & Sharpe, 1996;
Fox, 1999), all of which positively impact quality of life.
Two tools were used in this study to investigate the influence of RMST exercise on
participants’ quality of life. The Voice Handicap Index (VHI) specifically targeted the effects
of voice, while the Communication Participation Item Bank General Short Form (CPIB)
focused on impacts of a person’s “condition” (i.e. Parkinson’s disease). Results of the VHI
showed improvement in one participant, no change in another, and decline in the third. The
CPIB revealed the same mixed findings. However, results were not consistent between
measurement tools for each participant: some participants experienced improvement or
maintenance based on one tool while demonstrating decline based on the other, for example.
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A variety of factors may have influenced these results. First, although both tools
evaluated aspects of participants’ quality of life, each targeted slightly different areas.
Participants may have felt more or less impact from voice specifically, as opposed to the
disease in general. Furthermore, as reported by Baylor et al. (2011), other factors may either
facilitate or impede communicative participation for people with medical conditions. These
researchers interviewed 44 adults across seven different medical conditions, including PD.
Interviewees identified such variables as familiarity with communication partners,
unpredictability of the communication disorder and other health symptoms, and
environmental influences as having influenced quality of life. It can be expected that
participants in the current study shared these experiences, which may have been reflected in
their responses to the VHI and CPIB. This further highlights the complexity of Parkinson’s
disease and its impact on communication and quality of life. While shown to benefit many
symptoms of PD, RMST therefore should be recognized as merely one component of speech
and language treatment for individuals of this population. Further research is warranted to
determine the efficacy of RMST treatment on quality of life.
Limitations
There were several limitations to this study:


The study included a small sample size of only three participants, which restricts
generalization of results to all individuals with PD.



Participants were aware of the purpose of the study and had expressed desire for
improvement in targeted areas. This may have created a placebo effect, especially
regarding vocal quality and quality of life issues.
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Measurements of respiratory capacity and volumes were limited to FVC, FVC%,
and FEV1, which may have incompletely depicted of effects of RMST on
respiratory function.



Increased activities of daily life, particularly those requiring physical exertion,
were not closely monitored and may have contributed to increased respiratory
muscle strength during the detraining phase.



The researcher was unable to accurately measure the load on participants’
PowerLung devices to ensure that optimal settings of 60-80% of MIP and MEP
abilities, as suggested by Enright et al. (2006), were achieved.



During weekly meetings with the examiner, participants demonstrated proper
form and presented a written journal reporting completion of daily exercises and
any changes made to settings. However, the examiner could not directly monitor
training that occurred outside the clinic to ensure proper form and settings were
observed.
Conclusion

Results from this study suggest that RMST led to maintenance or improvement of
participants’ maximum inspiratory and expiratory pressures, vocal quality, and the quality of
life in several areas related to voice and communicative participation. Respiratory training
had inconsistent effects on participants’ ability to sustain vowel phonation, with two
participants increasing MPT and one participant decreasing MPT. RMST did not appear to
improve FVC, FVC%, or FEV1, although measurement of additional respiratory functions
(e.g. VC, TLC) may have provided a more complete depiction of its effects. Benefits of
RMST varied across participants, and improvements in MIP and MEP did not guarantee
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parallel results in other outcome measures. SLPs working with individuals with PD should
consider RMST as a treatment option for improving airway pressures and communication
abilities dependent on adequate pressures. However, other factors related to PD, such as stage
and progression of disease, pharmaceutical management, presentation of disease symptoms,
and external influences on communication also should be considered, as well as the
perceived benefit to the client.
Additional research in the areas of effects of RMST treatment on pulmonary function
and quality of life is recommended. Other suggested research includes short-term efficacy
studies, longitudinal studies with greater numbers of participants, time-series studies
measuring outcomes from time of onset, and combined RMST with other speech therapy.
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Appendix A
Perceptual Rating Form
Please mark the place on the line that best represents the client’s typical speech:
Always loud enough
Never loud enough
___________________________________________________________________
Never a “shaky” voice
Always a “shaky” voice
___________________________________________________________________
Never a hoarse
Always a hoarse
“scratchy” voice
“scratchy” voice”
___________________________________________________________________
Never monotone
Always monotone
___________________________________________________________________
Never slurs
Always slurs
___________________________________________________________________
Never a “strained” voice
Always a “strained” voice
___________________________________________________________________
Never mumbles
Always mumbles
___________________________________________________________________
Always speaks so
Never speaks so
others can understand
others can understand
___________________________________________________________________
Always participates
Never participates
in a conversation
in a conversation
___________________________________________________________________
Always starts a
Never starts a
conversation
conversation
___________________________________________________________________
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Table A1:
Responses to Perceptual Rating Form by Participant 1

Typical Speech
Always loud enough
Never a "shaky" voice
Never a "hoarse/scratchy" voice
Never monotone
Never Slurs
Never a "Strained" voice
Never mumbles
Always speaks, others understand

PostBaseline
Detraining End Phase 2
------------ % of Time ---------42.8%
56.9%
44.4%
31.4%
35.9%
43.8%
23.5%
35.9%
21.6%
36.4%
55.2%
42.8%
85.0%
95.4%
91.8%
38.2%
38.6%
41.8%
81.2%
38.6%
19.0%
37.3%
38.6%
39.9%

Always participates in
conversation
Always starts a conversation

85.0%
45.1%

62.7%
62.7%

17.3%
85.0%

Table A2:
Responses to Perceptual Rating Form by Participant 2 and Conversation Partner
Participant 2
------------- % of Time -------------

Typical Speech
Always Loud enough
Never a "shaky" voice
Never a "hoarse/scratchy" voice
Never monotone
Never slurs
Never a "strained" voice
Never mumbles
Always speaks, others understand
Participates in a conversation
Starts a conversation

Baseline
81.7%
12.4%
80.4%
92.2%
96.1%
82.4%
84.3%
73.9%
86.0%
92.8%

PostEnd
Detraining Phase 2
80.0%
90.2%
98.0%
96.1%
95.4%
95.4%
88.0%
80.1%
96.0%
95.8%
97.4%
94.1%
94.1%
91.5%
92.0%
87.9%
96.7%
89.9%
79.0%
81.1%

Conversation
Partner
--- % of Time --End
End
Phase
Phase 1
2
74.5%
77.8%
98.7%
93.1%
98.7%
99.4%
73.9%
72.9%
xx
97.4%
99.0%
96.7%
71.9%
77.8%
86.9%
81.4%
99.0%
99.7%
99.3%
98.0%
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Table A3:
Responses to Perceptual Rating Form by Participant 3 and Conversation Partner
Participant 3
------------- % of Time -------------

Typical Speech
Always loud enough
Never a "shaky" voice
Never a "hoarse/scratchy" voice
Never monotone
Never Slurs
Never a "Strained" voice
Never mumbles
Always speaks, others understand
Always participates in conversation
Always starts a conversation

Baseline
38.6%
50.0%
50.0%
65.0%
48.7%
33.0%
53.6%
45.1%
52.9%
43.1%

PostEnd
Detraining Phase 2
44.0%
27.8%
44.0%
81.4%
55.0%
67.7%
62.7%
67.3%
73.9%
74.8%
53.6%
51.6%
43.0%
71.2%
50.0%
49.7%
78.0%
70.9%
43.0%
46.1%

Conversation
Partner
--- % of Time --End
End
Phase
Phase 1
2
50.3%
41.8%
67.2%
72.9%
88.9%
74.5%
70.9%
77.5%
91.2%
69.9%
88.6%
69.3%
69.3%
58.5%
89.5%
64.1%
98.4%
82.7%
97.4%
85.0%
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Appendix B
Voice Handicap Index (VHI)
Instructions: These are statements that many people have used to describe their voices and
the effects of their voices on their lives. Check the response that indicates how frequently
you have the same experience.
Never
F1
P2
F3
P4
F5
F6
E7
F8
E9
P10
F11
F12
P13
P14
E15
F16
P17
P18

Almost
Never

Sometimes

Almost
Always

Always

My voice makes it difficult for
people to hear me
I run out of air when I talk
People have difficulty
understanding me in a noisy
room
The sound of my voice varies
throughout the day
My family has difficulty hearing
me when I call them throughout
the house
I use the phone less often than I
would like
I’m tense when talking with
others because of my voice
I tend to avoid groups of people
because of my voice
People seem irritated with my
voice
People ask, “What’s wrong with
your voice?”
I speak with friends, neighbors
or relatives less often because of
my voice
People ask me to repeat myself
when speaking face-to-face
My voice sounds creaky and dry
I feel as though I have to strain
to produce voice
I find other people don’t
understand my voice problem
My voice difficulties restrict my
personal and social life
The clarity of my voice is
unpredictable
I try to change my voice to
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F19
P20
P21
F22
E23
E24
E25
P26
E27
E29
E30

sound different
I feel left out of conversations
because of my voice
I use a great deal of effort to
speak
My voice is worse in the evening
My voice problem causes me to
lose income
My voice problem upsets me
I am less out-going because of
my voice problem
My voice problem makes me
feel handicapped
My voice “gives out” on me in
the middle of speaking
I feel annoyed when people ask
me to repeat
I feel embarrassed when people
ask me to repeat
I’m ashamed of my voice
problem

Table B1:
Participant 1: Results of Voice Handicap Index
Baseline

End Phase 2

Post-Detraining

Raw
Score

Severity

Raw
Score

Severity Rating

Raw
Score

Severity Rating

P Scale (physical)

19

Moderate

21

Moderate-Severe

20

Moderate-Severe

F Scale (functional)

18

Severe

17

Moderate-Severe

13

Moderate

E Scale (emotional)

9

Mild

8

Mild

9

Mild

Total

46

Moderate-Severe

46

Moderate-Severe

42

Moderate-Severe

Table B2:
Participant 2: Results of Voice Handicap Index
Baseline

End Phase 2

Post-Detraining

Raw
Score

Severity Rating

Raw
Score

Severity Rating

Raw
Score

Severity Rating

P Scale (physical)

10

Mild

5

Mild

6

Mild

F Scale (functional)

7

Mild

5

Mild

11

Mild-Moderate

E Scale (emotional)

1

Mild

4

Mild

5

Mild

Total

18

Mild

14

Mild

22

Mild
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Table B3:
Participant 3: Results of Voice Handicap Index
Baseline

End Phase 2

Post-Detraining

Raw
Score

Severity Rating

Raw
Score

Severity Rating

Raw
Score

Severity Rating

P Scale (physical)

23

Severe

21

Moderate-Severe

23

Severe

F Scale (functional)

20

Severe

19

Severe

23

Severe

E Scale (emotional)

17

Moderate-Severe

15

Moderate

17

Moderate-Severe

Total

60

Moderate-Severe

55

Moderate-Severe

63

Severe
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Appendix C
Communication Participation Item Bank
Instructions: The following questions describe a variety of situations in which you might
need to speak to others. For each question, please mark how much your condition interferes
with your participation in that situation. By “condition” we mean ALL issues that may affect
how you communicate in these situations including speech conditions, any other health
conditions, or features of the environment. If you speech varies, think about an AVERAGE
day for your speech – not your best or your worst days.

1. Does your condition interfere
with……talking with people you
know?
2. Does your condition interfere
with……communicating when
you need to say something
quickly?
3. Does your condition interfere
with……talking with people you
do NOT know?
4. Does your condition interfere
with……communicating when
you are out in your community
(e.g. errands; appointments)?
5. Does your condition interfere
with……asking questions in a
conversation?
6. Does your condition interfere
with……communicating in a
small group of people?
7. Does your condition interfere
with……having a long
conversation with someone you
know about a book, movie, show
or sports event?
8. Does your condition interfere
with……giving someone
DETAILED information?
9. Does your condition interfere
with……getting your turn in a
fast-moving conversation?
10. Does your condition interfere
with……trying to persuade a
friend or family member to see a
different point of view?

Not at all
(3)

A little
(2)

Quite a bit
(1)

Very much
(0)
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Table C1:
Participant 1: Communication Participation Item Bank – General Short Form

Summary Score:
IRT Theta:
T score:
Interference in participation:

Baseline
27
1.22
62.2
Mild

PostDetraining
25
0.92
59.2
Mild

End Phase 2
25
0.92
59.2
Mild

Table C2:
Participant 2: Communication Participation Item Bank – General Short Form

Summary Score
IRT Theta
T score
Interference in participation:

Baseline
21
0.4
54
Mild-Moderate

PostDetraining
17
-0.1
49
Moderate

End Phase 2
17
-0.1
49
Moderate

Table C3:
Participant 3: Communication Participation Item Bank – General Short Form

Summary Score
IRT Theta
T score
Interference in participation:

Baseline
16
-0.22
47.8
Moderate

PostDetraining
16
-0.22
47.8
Moderate

End Phase 2
19
0.15
51.5
Mild-Moderate
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